(Q43783464)

26 November 2017

title

HIV-specific immunity during structured antiviral drug treatment interruption (English)

1 reference

26 November 2017

Ronald B Moss

1

1 reference

26 November 2017

Carolyn Brandt

2

1 reference

26 November 2017

Wieslawa K Giermakowska

3

1 reference

26 November 2017

Jay R Savary

4

1 reference

26 November 2017

Georgia Theofan

5

1 reference

26 November 2017

Maurizio Zanetti

6

1 reference

26 November 2017

Dennis J Carlo

7

1 reference

26 November 2017

Mark R Wallace

8

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 March 2003

1 reference

26 November 2017

number of pages

6

1 reference

inferred from page(s)

published in

Vaccine

1 reference

26 November 2017

volume

21

1 reference

26 November 2017

issue

11-12

1 reference

26 November 2017

page(s)

1066-1071

1 reference

Less is more? STI in acute and chronic HIV-1 infection

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Structured treatment interruptions for the management of HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+ and CD4+ T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Immune control of HIV-1 after early treatment of acute infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Control of SIV rebound through structured treatment interruptions during early infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

High-level HIV-1 viremia suppresses viral antigen-specific CD4(+) T cell proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

HIV dynamics and T-cell immunity after three structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

The virological and immunological consequences of structured treatment interruptions in chronic HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

HIV type 1 isolate Z321, the strain used to make a therapeutic HIV type 1 immunogen, is intersubtype recombinant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Human immunodeficiency virus isolated from a serum sample collected in 1976 in Central Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Investigations of the use of beta-propiolactone in virus inactivation

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Effect of gamma irradiation on the human immunodeficiency virus and human coagulation proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

HIV-1-Specific CD4 helper function in persons with chronic HIV-1 infection on antiviral drug therapy as measured by ELISPOT after treatment with an inactivated, gp120-depleted HIV-1 in incomplete Freund's adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Effect of immunization with an inactivated gp120-depleted HIV-1 immunogen on beta-chemokine and cytokine production in subjects with HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2802%2900610-2

7 January 2021

10.1016/S0264-410X(02)00610-2

Identifiers

DOI

1 reference

26 November 2017

1 reference